Pharmagene plc (“Pharmagene” or the “Group”) was renamed Asterand plc following the merger with Asterand, Inc., which was approved by shareholders on 22 December 2005 and was completed in all respects on 3 January 2006 upon the admission of the enlarged share capital to the Official List. These preliminary results cover Pharmagene plc prior to the merger. In addition, a summary of Asterand, Inc.’s trading performance in 2005 has also been provided. Asterand, Inc.’s results do not form a part of the consolidated results of Pharmagene plc for 2005. Throughout this statement “Pharmagene” and “Asterand, Inc.” refer to the two companies separately prior to the merger. When looking to the future the enlarged group following the merger is referred to by its new name – Asterand plc.
